| pubmed-article:7810529 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7810529 | lifeskim:mentions | umls-concept:C0019004 | lld:lifeskim |
| pubmed-article:7810529 | lifeskim:mentions | umls-concept:C0025255 | lld:lifeskim |
| pubmed-article:7810529 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:7810529 | lifeskim:mentions | umls-concept:C0032712 | lld:lifeskim |
| pubmed-article:7810529 | lifeskim:mentions | umls-concept:C0728940 | lld:lifeskim |
| pubmed-article:7810529 | lifeskim:mentions | umls-concept:C0013682 | lld:lifeskim |
| pubmed-article:7810529 | lifeskim:mentions | umls-concept:C0015252 | lld:lifeskim |
| pubmed-article:7810529 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:7810529 | pubmed:dateCreated | 1995-1-31 | lld:pubmed |
| pubmed-article:7810529 | pubmed:abstractText | To assess the capability of three different membranes to remove porphyrins, plasma and dialysate porphyrin levels were fluorometrically measured in 10 patients with end-stage renal failure who were on hemodialysis. Three different hemodialysis membranes were used: cuprophan, polyacrylonitrile, and cellulose triacetate. Total plasma porphyrin concentrations decreased after dialysis, but to a lesser extent when using the cuprophan membrane (19%) than with the polyacrylonitrile (26%) or cellulose triacetate (30%) membranes (P < 0.01). However, since the free plasma porphyrin fraction remained unchanged, it can be assumed that the equilibrium between protein-bound and non-protein-bound (free) porphyrins is displaced toward the latter fraction. Dialysate porphyrin levels were lower (P < 0.01) when using the cuprophan membrane (10.1 micrograms/session) than when using polyacrylonitrile (17.8 micrograms/session) and cellulose triacetate (21.9 micrograms/session). Although most of the plasma porphyrins are protein bound, our results show that hemodialysis can remove significant amounts of non-protein-bound (free) porphyrins. The polyacrylonitrile and cellulose triacetate membranes had a greater capacity for porphyrin removal than cuprophan. Thus, two high-permeability membranes (polyacrylonitrile and cellulose triacetate) should be used whenever a reduction of plasma porphyrin levels is desired. | lld:pubmed |
| pubmed-article:7810529 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7810529 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7810529 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7810529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7810529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7810529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7810529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7810529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7810529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7810529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7810529 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7810529 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7810529 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:7810529 | pubmed:issn | 0272-6386 | lld:pubmed |
| pubmed-article:7810529 | pubmed:author | pubmed-author:BarrientosAA | lld:pubmed |
| pubmed-article:7810529 | pubmed:author | pubmed-author:MoranM JMJ | lld:pubmed |
| pubmed-article:7810529 | pubmed:author | pubmed-author:SepulvedaPP | lld:pubmed |
| pubmed-article:7810529 | pubmed:author | pubmed-author:CoronelFF | lld:pubmed |
| pubmed-article:7810529 | pubmed:author | pubmed-author:HerreroJ AJA | lld:pubmed |
| pubmed-article:7810529 | pubmed:author | pubmed-author:FontanellasAA | lld:pubmed |
| pubmed-article:7810529 | pubmed:author | pubmed-author:Enriquez De... | lld:pubmed |
| pubmed-article:7810529 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7810529 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:7810529 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7810529 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7810529 | pubmed:pagination | 30-3 | lld:pubmed |
| pubmed-article:7810529 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:7810529 | pubmed:meshHeading | pubmed-meshheading:7810529-... | lld:pubmed |
| pubmed-article:7810529 | pubmed:meshHeading | pubmed-meshheading:7810529-... | lld:pubmed |
| pubmed-article:7810529 | pubmed:meshHeading | pubmed-meshheading:7810529-... | lld:pubmed |
| pubmed-article:7810529 | pubmed:meshHeading | pubmed-meshheading:7810529-... | lld:pubmed |
| pubmed-article:7810529 | pubmed:meshHeading | pubmed-meshheading:7810529-... | lld:pubmed |
| pubmed-article:7810529 | pubmed:meshHeading | pubmed-meshheading:7810529-... | lld:pubmed |
| pubmed-article:7810529 | pubmed:meshHeading | pubmed-meshheading:7810529-... | lld:pubmed |
| pubmed-article:7810529 | pubmed:meshHeading | pubmed-meshheading:7810529-... | lld:pubmed |
| pubmed-article:7810529 | pubmed:meshHeading | pubmed-meshheading:7810529-... | lld:pubmed |
| pubmed-article:7810529 | pubmed:meshHeading | pubmed-meshheading:7810529-... | lld:pubmed |
| pubmed-article:7810529 | pubmed:meshHeading | pubmed-meshheading:7810529-... | lld:pubmed |
| pubmed-article:7810529 | pubmed:meshHeading | pubmed-meshheading:7810529-... | lld:pubmed |
| pubmed-article:7810529 | pubmed:meshHeading | pubmed-meshheading:7810529-... | lld:pubmed |
| pubmed-article:7810529 | pubmed:meshHeading | pubmed-meshheading:7810529-... | lld:pubmed |
| pubmed-article:7810529 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7810529 | pubmed:articleTitle | Efficiency of three different hemodialysis membranes for plasma porphyrin removal. | lld:pubmed |
| pubmed-article:7810529 | pubmed:affiliation | Porphyria Unit, Hospital Universitario Doce de Octubre, Madrid, Spain. | lld:pubmed |
| pubmed-article:7810529 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7810529 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7810529 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:7810529 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| pubmed-article:7810529 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
